ALYREF and ovarian carcinoma: We next investigated the effects of overexpressing and knocking down ALYREF (shALY-1 and shALY-2) on the growth and migration of ovarian cancer cell lines, including A2780, OVCAR3, and SKOV3 cells (Fig. EV1D,E).